Rigel Pharmaceuticals (RIGL) Free Cash Flow (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Free Cash Flow of $2.7 million for Q1 2026, up 405.15% year-over-year from $539442.5 in Q1 2025, and down 87.6% quarter-over-quarter from $22.0 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Free Cash Flow (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Free Cash Flow history runs 17 years deep, the most recent figure standing at $2.7 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 405.15% year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $79.3 million (up 122.73% YoY), while the FY2025 annual figure was $75.7 million, up 140.4% from the prior year.
- Free Cash Flow for Q1 2026 stood at $2.7 million, down from $22.0 million in the prior quarter.
- The five-year high for Free Cash Flow was $30.5 million in Q2 2025, with the low at -$25.9 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$893000.0 (2025), against an average of $1.8 million.
- The sharpest annual moves came in 2022 and 2025: Free Cash Flow plunged 123.52% in 2022, then surged 10011.59% in 2025.
- Rigel Pharmaceuticals' Free Cash Flow stood at -$22.8 million in 2022, then jumped by 72.56% to -$6.3 million in 2023, then surged by 331.34% to $14.5 million in 2024, then soared by 51.55% to $22.0 million in 2025, then tumbled by 87.6% to $2.7 million in 2026.
- Business Quant data shows RIGL's Free Cash Flow at $2.7 million in Q1 2026, $22.0 million in Q4 2025, and $24.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 30.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.65 Mn |
| Jun 30, 2026 | 30.65 Mn |
| Mar 31, 2026 | 2.73 Mn |
| Mar 31, 2026 | 2.73 Mn |
| Dec 31, 2025 | 21.98 Mn |
| Dec 31, 2025 | 21.98 Mn |
| Sep 30, 2025 | 24.03 Mn |
| Sep 30, 2025 | 24.03 Mn |
| Jun 30, 2025 | 30.54 Mn |
| Jun 30, 2025 | 30.54 Mn |
| Mar 31, 2025 | -893,000.00 |
| Mar 31, 2025 | -893,000.00 |
| Dec 31, 2024 | 14.50 Mn |
| Dec 31, 2024 | 14.50 Mn |
| Sep 30, 2024 | 21.68 Mn |
| Sep 30, 2024 | 21.68 Mn |
| Jun 30, 2024 | 302,000.00 |
| Jun 30, 2024 | 302,000.00 |
| Mar 31, 2024 | -5.01 Mn |
| Mar 31, 2024 | -5.01 Mn |